News FDA approves leucovorin – but not for autism The FDA stops short of approving leucovorin for autism, but will its clearance for ultra-rare condition CFD-FOLR1 lead to more off-label prescribing?
News Medical group advises against leucovorin for autism The American Academy of Paediatrics has warned against leucovorin as a treatment for autism, citing a lack of evidence on safety and efficacy.
News Texas sues J&J, Kenvue over Tylenol autism claim Texas has filed a lawsuit against J&J and Kenvue over the debunked claim that Tylenol causes autism, recently trumpeted by President Trump.
News Alarm as Trump peddles unproven causes of autism Medical groups have reacted with dismay after Trump linked childhood vaccinations and use of acetaminophen to autism.
News RFK Jr launches database project to explore autism causes A project to use federal databases to identify the "root causes of autism" has been launched by HHS, but there are concerns about its credibility.
News Server cans autism hope bumetanide after phase 3 fails Servier and Neurochlore have been forced to admit defeat in their bid to bring the first drug to market for people with autism spectrum disorder (ASD), after a comprehensive fail for their
News GSK pursues $10.6bn takeover of cancer biotech Nuvalent GSK is preparing for its biggest acquisition in more than 10 years, agreeing to buy cancer drug developer Nuvalent for $10.6 billion.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.